Understanding the experience of living with non-small-cell lung cancer (NSCLC): A qualitative study

Journal of Community and Supportive Oncology

Volumn 12, Issue 1, 2014, Pages 6-12

  Buzaglo, Joanne ^a   Gayer, Christopher ^a   Mallick, Rajiv ^b   Charap, Ellyn ^c   Ferris, Andrea ^d   Golant, Mitch ^a   Langer, Corey ^e   Morris, Anne ^a   Mullins, C Daniel ^f   Cella, David ^g  

^a Cancer Support Community (CSC) Research and Training Institute   (United States)

^b DAIICHI SANKYO INC   (United States)

^c Independent researcher ^*  (United States)

^d LUNGevity Foundation   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BILLING AND CLAIMS; BIOLOGICAL THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY; EMOTION; FEAR; FEMALE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HUMAN; LIFE EXTENSION; LONELINESS; MALE; MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; PATIENT ADVOCACY; PATIENT DECISION MAKING; PATIENT EDUCATION; PEER GROUP; PERSONAL EXPERIENCE; QUALITATIVE RESEARCH; QUALITY OF LIFE; SENSATION; SOCIAL SUPPORT; SUPPORT GROUP; TELEPHONE INTERVIEW; TIME TO TREATMENT;

EID: 84946562335     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0010     Document Type: Article

References (33)

1. American Cancer Society. Cancer treatment & survivorship facts & fgures 2012-2013. Atlanta, GA: American Cancer Society; 2012
2. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a National Cancer Data Base report. Cancer. 1999; 86(9): 1867-1876
3. Yang P. Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol. 2009; 471: 469-486
4. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. Te prevalence of psychological distress by cancer site. Psychooncology. 2001; 10(1): 19-28
5. Kennard BD, Stewart SM, Olvera R., et al. Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings. 2004; 11: 31-39
6. Kukull WA, McCorkle R, Driever M. Symptom distress, psychosocial variables, and survival from lung cancer. J Psychosoc Oncol. 1986; 4(1-2): 91-104
7. New Commission on Cancer accreditation standards gain strong support from four national cancer advocacy organizations [press release]. Chicago, IL: American College of Surgeons; August 31, 2011
8. Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. In: Adler NE, Page AEK, eds. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: National Academies Press; 2008; 1-21
9. National Comprehensive Cancer Network. Distress management clinical practice guidelines. J Natl Compr Canc Netw. 2003; 1(3): 344-374
10. Derogatis LR. Brief Symptom Inventory 18: Administration, Scoring, and Procedures Manual. Minneapolis, MN: NCS Pearson; 2001
11. Jacobsen PB, Donovan KA, Trask PC., et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005; 103(7): 1494-1502
12. Radlof L. Te CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401
13. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998; 82(10): 1904-1908
14. Watanabe SM, Nekolaichuk CL, Beaumont C. Te Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refnement. Psychooncology. 2012; 21(9): 977-985
15. Hodgkinson K, Bulow P, Hunt GE., et al. Te development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure). Psychooncology. 2007; 16(9): 796-804
16. Lowery AE, Greenberg MA, Foster SL., et al. Validation of a needsbased biopsychosocial distress instrument for cancer patients. Psychooncology. 2012; 21(10): 1099-1106
17. Schag CA, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System short form (CARES-SF). A cancer specifc rehabilitation and quality of life instrument. Cancer. 1991; 68(6): 1406-1413
18. Shim EJ, Lee KS, Park JH, Park JH. Comprehensive needs assessment tool in cancer (CNAT): the development and validation. Support Care Cancer. 2011; 19(12): 1957-1968
19. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative afect: the PANAS scales. J Pers Soc Psychol. 1988; 54(6): 1063-1070
20. Iglehart JK. Changing health insurance trends. N Engl J Med. 2002; 347(12): 956-962
21. Glaser BG, Strauss AL. Discovery of grounded theory: Strategies for qualitative research. London, England: Weidenfeld and Nicolson; 1967
22. Delbecq AL, Van de Ven AH. A group process model for problem identifcation and program planning. J Appl Behav Sci. 1971; 7(4): 466-492
23. Patrick DL, Burke LB, Gwaltney CJ., et al. Content validity establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report. Part 2 assessing respondent understanding. Value Health. 2011; 14(8): 978-988
24. Strauss A, Corben J. Basics of qualitative research: Techniques and procedures for developing grounded theory. 2nd ed. London, England: Sage Publications; 1998
25. Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010; 10(3): 269-281
26. Lasch KE, Marquis P, Vigneux M., et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010; 19(8): 1087-1096
27. Magasi S, Mallick R, Kaiser K., et al. Importance and relevance of pulmonary symptoms among patients receiving second- and thirdline treatment for advanced nonsmall-cell lung cancer: support for the content validity of the 4-Item pulmonary symptom index. Clin Lung Cancer. 2013; 14(3): 245-253
28. Yount S, Beaumont J, Rosenbloom S., et al. A brief symptom index for advanced lung cancer. Clin Lung Cancer. 2012; 13(1): 14-23
29. Cella DF, Orofiamma B, Holland JC., et al. Te relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer. 1987; 60(7): 1661-1667
30. Mehnert A, Koch U. Psychological comorbidity and healthrelated quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res. 2008; 64(4): 383-391
31. Ramsey SD, Fedorenko CR, Snell KS, Kirchhof AC, Hollingworth W, Blough DK. Cancer diagnosis as a risk factor for personal bankruptcy (ASCO abstract 6007). J Clin Oncol. 2011; 29(suppl
32. Cella DF, Tulsky DS, Gray G., et al. Te Functional Assessment of Cancer Terapy scale: development and validation of the general measure. J Clin Oncol.1993; 11(3): 570-579
33. Wagner LI, Spiegel D, Pearman T. Using the science of psychosocial care to implement the new American College of Surgeons Commission on Cancer distress screening standard. J Natl Compr Canc Netw. 2013; 11(2): 214-221